Prevention of adverse reactions to Amipaque in cervical myelography. Report of a homogeneous series of 380 patients.
D000328:Adult; D000368:Aged; D002574:Cervical Vertebrae; D003128:Coma / Q000139:chemically induced; D003221:Confusion / Q000139:chemically induced; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced*; D005260:Female; D006429:Hemiplegia / Q000139:chemically induced; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging*; D008297:Male; D008793:Metrizamide / Q000009:adverse effects*; D008875:Middle Aged; D009192:Myelography / Q000009:adverse effects*; D013118:Spinal Cord Diseases / Q000000981:diagnostic imaging*; D013122:Spinal Diseases / Q000000981:diagnostic imaging*
D008793:Metrizamide